Global Healthcare Leader Organon Licenses Sebela Pharmaceuticals’ MIUDELLA for Diverse Reproductive Health Needs Why is the landscape of women’s reproductive health evolving so rapidly? Organon a global healthcare company with a mission…
BXLS and Johnson & Johnson Collaborate to Fund Bleximenib Clinical Trials for AML Why is the development of new treatments for acute myeloid leukemia (AML) so critical? Despite being the…
Pulse Biosciences Awards Equity to New Hires to Drive Growth and Innovation In the competitive landscape of biotechnology, where innovation and talent retention are paramount, Pulse Biosciences, Inc. stands out…
Science and Neurosoft Team Up to Reduce BCI Development Costs and Time Science Corporation, a pioneering full-stack neural engineering company, and Neurosoft Bioelectronics, a neural data company, have announced a…
Union President Demands Premier Houston to Invest in Public Services Why is the Nova Scotia government prioritizing private contracts over public service workers? CUPE Nova Scotia, a union representing long-term…
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Savara Inc. a clinical-stage biopharmaceutical company focused…
Animate Biosciences Reports Preclinical Data Showing Dramatic Reduction in Cardiac Scarring and Near-Doubling of Heart Function After Experimental Heart Attack Animate Biosciences, a biotechnology company focused on designing innovative peptide…
bit.bio Accelerates Global Access to Human Cells with New Pricing Model and Distribution Hub Following a record Q4 in sales volume and the successful closing of $50 million in new…
Unified Women’s Healthcare Responds to Rising Demand for Menopause Care Unified Women’s Healthcare (Unified), in partnership with its OBGYN affiliates, is expanding access to perimenopause and menopause care nationwide through Unified for…
NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis NexEos Bio Vision Health a clinical-stage biopharmaceutical company developing novel therapies…
RestorixHealth Announces 2025 Center Recognition Awards Program Recipients RestorixHealth, the nation’s leading wound care solutions company, is pleased to announce the wound and hyperbaric center recipients of their Center Recognition…
VB Spine Announces Intent to Acquire Exclusive Rights to Augmedics’ Spine Platform VB Spine LLC the largest privately held spine company, today announced it has entered into a definitive agreement…